Processa Pharmaceuticals, Inc.
PCSA
Revenue
0.00
0.000.00%
12 Months ChangeAssets
4.94M
▼-2.66M▼-34.98%
3 Months ChangeLiabilities
1.22M
▼-355.95k▼-22.57%
3 Months ChangeFree Cash Flow
-59.58k
▲443.91k▲88.17%
24 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-30
Form 10-Q
ID: 0001493152-24-043058
2024-10-02
Form 8-K
ID: 0001493152-24-039220
2024-08-28
Form 8-K
ID: 0001493152-24-034115
2024-08-13
Form 10-Q
ID: 0001493152-24-031622
2024-07-30
Form 8-K
ID: 0001493152-24-029514
2024-07-17
Form 8-K
ID: 0001493152-24-028093
2024-07-02
Form 8-K
ID: 0001493152-24-025884
2024-05-21
Form 8-K
ID: 0001493152-24-020883
2024-05-10
Form 10-Q
ID: 0001493152-24-018648
2024-04-11
Form 8-K
ID: 0001493152-24-014278